19-8510886-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001146175.2(ZNF414):​c.1064C>T​(p.Pro355Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00127 in 1,124,106 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0017 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 6 hom. )

Consequence

ZNF414
NM_001146175.2 missense

Scores

2
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0810
Variant links:
Genes affected
ZNF414 (HGNC:20630): (zinc finger protein 414) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041778684).
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZNF414NM_001146175.2 linkc.1064C>T p.Pro355Leu missense_variant Exon 7 of 8 ENST00000393927.9 NP_001139647.1 Q96IQ9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZNF414ENST00000393927.9 linkc.1064C>T p.Pro355Leu missense_variant Exon 7 of 8 1 NM_001146175.2 ENSP00000377504.3 Q96IQ9-2

Frequencies

GnomAD3 genomes
AF:
0.00175
AC:
255
AN:
145660
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000147
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000407
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00523
Gnomad MID
AF:
0.00327
Gnomad NFE
AF:
0.00290
Gnomad OTH
AF:
0.000492
GnomAD2 exomes
AF:
0.00496
AC:
18
AN:
3632
AF XY:
0.00485
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00729
Gnomad NFE exome
AF:
0.00156
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00120
AC:
1175
AN:
978334
Hom.:
6
Cov.:
32
AF XY:
0.00125
AC XY:
577
AN XY:
460962
show subpopulations
African (AFR)
AF:
0.000154
AC:
3
AN:
19480
American (AMR)
AF:
0.00108
AC:
6
AN:
5530
Ashkenazi Jewish (ASJ)
AF:
0.0000969
AC:
1
AN:
10324
East Asian (EAS)
AF:
0.00
AC:
0
AN:
18500
South Asian (SAS)
AF:
0.00169
AC:
32
AN:
18928
European-Finnish (FIN)
AF:
0.00653
AC:
141
AN:
21578
Middle Eastern (MID)
AF:
0.00250
AC:
6
AN:
2402
European-Non Finnish (NFE)
AF:
0.00112
AC:
950
AN:
844744
Other (OTH)
AF:
0.000977
AC:
36
AN:
36848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.541
Heterozygous variant carriers
0
63
126
188
251
314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00174
AC:
254
AN:
145772
Hom.:
2
Cov.:
32
AF XY:
0.00186
AC XY:
132
AN XY:
70920
show subpopulations
African (AFR)
AF:
0.000147
AC:
6
AN:
40798
American (AMR)
AF:
0.000407
AC:
6
AN:
14750
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3414
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5108
South Asian (SAS)
AF:
0.00146
AC:
7
AN:
4804
European-Finnish (FIN)
AF:
0.00523
AC:
44
AN:
8412
Middle Eastern (MID)
AF:
0.00350
AC:
1
AN:
286
European-Non Finnish (NFE)
AF:
0.00290
AC:
189
AN:
65236
Other (OTH)
AF:
0.000487
AC:
1
AN:
2054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00142
Hom.:
0
Bravo
AF:
0.000963
ExAC
AF:
0.000406
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 12, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1064C>T (p.P355L) alteration is located in exon 7 (coding exon 7) of the ZNF414 gene. This alteration results from a C to T substitution at nucleotide position 1064, causing the proline (P) at amino acid position 355 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
6.6
DANN
Benign
0.80
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.078
N
LIST_S2
Benign
0.44
T
M_CAP
Benign
0.036
D
MetaRNN
Benign
0.0042
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.081
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-0.58
N
REVEL
Benign
0.019
Sift
Benign
0.034
D
Sift4G
Uncertain
0.0050
D
Vest4
0.079
MVP
0.072
MPC
0.23
ClinPred
0.013
T
GERP RS
-0.055
gMVP
0.20
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs576116806; hg19: chr19-8575770; API